Cédric Bisson

Bio

Cédric Bisson is the partner in charge of life sciences at iNovia Capital. He leads investments in that sector with a focus on biopharmaceuticals and medical devices. Prior to joining iNovia in 2003, Mr Bisson was an associate principal at McKinsey & Company, a leading global management consulting firm, where he co-led the Canadian healthcare (including pharma, biotech and private equity) and innovation practices; during this time, he also pursued extensive professional activities in Montréal, New York City and Paris in pharmaceutical and medical devices. Mr Bisson currently serves or has served as a board member to Iaculor Injection, Milestone Pharmaceuticals, Mimetogen Pharmaceuticals and Resonant Medical. He is an active member of many life sciences initiatives in Canada and abroad, and is also a member of the boards of BIOQuébec (Québec’s life sciences industry association) and Procure (a non-profit charity against prostate cancer). Mr Bisson obtained an MD degree from McGill University and a JD (law) degree from Université de Montréal.